These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18338236)

  • 41. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
    Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bare metal stent thrombosis 13 years after implantation.
    Sarkees ML; Bavry AA; Galla JM; Bhatt DL
    Cardiovasc Revasc Med; 2009; 10(1):58-9. PubMed ID: 19159857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
    Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
    Kufner S; Massberg S; Dommasch M; Byrne RA; Tiroch K; Ranftl S; Fusaro M; Schömig A; Kastrati A; Mehilli J;
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):161-6. PubMed ID: 21400652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility of assessment of coronary stent patency using 16-slice computed tomography.
    Schuijf JD; Bax JJ; Jukema JW; Lamb HJ; Warda HM; Vliegen HW; de Roos A; van der Wall EE
    Am J Cardiol; 2004 Aug; 94(4):427-30. PubMed ID: 15325923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.
    Stefanini GG; Kalesan B; Pilgrim T; Räber L; Onuma Y; Silber S; Serruys PW; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Mar; 5(3):301-10. PubMed ID: 22440496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Chung JH; Shin ES; Her AY; Lee JM; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):179-185. PubMed ID: 31598811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.
    Abizaid A; Popma JJ; Tanajura LF; Hattori K; Solberg B; Larracas C; Feres F; Costa Jde R; Schwartz LB
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):914-9. PubMed ID: 18044791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Origin of the right coronary artery from the opposite sinus of Valsalva in adults: characterization by intravascular ultrasonography at baseline and after stent angioplasty.
    Angelini P; Uribe C; Monge J; Tobis JM; Elayda MA; Willerson JT
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):199-208. PubMed ID: 26178792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
    Vlaar PJ; Zijlstra F
    JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547
    [No Abstract]   [Full Text] [Related]  

  • 53. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of myocardial perfusion defects and nonsignificant coronary lesions by angiography with insights from intravascular ultrasound and coronary pressure measurements.
    Rodés-Cabau J; Candell-Riera J; Angel J; de León G; Pereztol O; Castell-Conesa J; Soto A; Anívarro I; Aguadé S; Vázquez M; Domingo E; Tardif JC; Soler-Soler J
    Am J Cardiol; 2005 Dec; 96(12):1621-6. PubMed ID: 16360346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR; Vaknin-Assa H; Lev E; Teplitsky I; Dvir D; Brosh D; Bental T; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):615-22. PubMed ID: 22162218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus.
    Suzuki N; Nanda H; Angiolillo DJ; Bezerra H; Sabaté M; Jiménez-Quevedo P; Alfonso F; Macaya C; Bass TA; Ilegbusi OJ; Costa MA
    Int J Cardiovasc Imaging; 2008 Apr; 24(4):357-64. PubMed ID: 17972162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low coronary flow velocity and shear stress predict restenosis after sirolimus-eluting stent implantation.
    Hikita H; Sato A; Nozato T; Kawashima T; Takahashi Y; Kuwahara T; Takahashi A
    Scand Cardiovasc J; 2009; 43(5):298-303. PubMed ID: 19263268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stent implantation is effective treatment of vascular stenosis in young infants with congenital heart disease: acute implantation and long-term follow-up results.
    Stanfill R; Nykanen DG; Osorio S; Whalen R; Burke RP; Zahn EM
    Catheter Cardiovasc Interv; 2008 May; 71(6):831-41. PubMed ID: 18412081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.